Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2008-12-31
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolomics in Surgical Ophthalmological Patients
NCT03098316
Incidence of Dyschromatopsia in Glaucoma
NCT02966678
Nicotinamide Levels in Serum, Aqueous Humor, and Tear Film in Glaucoma and Correlations With Mitochondrial Damage-Associated Molecular Patterns (mtDAMPs) and Senescence-Associated Secretory Phenotype (SASP)
NCT07006194
Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease
NCT00691340
Ability of Patients With Low Vision to Properly Instill Eye Drops
NCT00760240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
glaucoma patients
drawing blood sample
fasting blood sample
2
non-glaucoma controls
drawing blood sample
fasting blood sample
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
drawing blood sample
fasting blood sample
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* glaucoma
Exclusion Criteria
* Ocular Hypertension
* Nephropathy
* Alcohol-, Drug abuse
* Mitochondriopathy
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kantonsspital Baselland Bruderholz
OTHER
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Goldblum, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Josef Flammer, MD
Role: STUDY_CHAIR
University Hospital, Basel, Switzerland
Selim Orguel, MD
Role: STUDY_DIRECTOR
University Hospital, Basel, Switzerland
Stephan Fraenkl, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Basel, Switzerland
Fabrizio Branca, MD
Role: PRINCIPAL_INVESTIGATOR
University Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Basel
Basel, Canton of Basel-City, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK 325/08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.